Investor Stock List
#6,864 by institutional money · Stock

Eloxx Pharmaceuticals, Inc. (ELOX)

Institutional ownership from Q3 2026 Form 13F filings

$10.65
+2.31% today
Market closed. Prices as of Nov 20, 7:41 AM ET
13F holders
20 (−2)
Held by 13F filers, live
$28.8M
Shares held
2,700,412
Share of stock outstanding
66.1%
Net buying in Q3 2026
−$2.1M
New positions / sold out
3 / 5

Largest holders

20 investors
InvestorSharesValue, live% of their portfoliovs Q2 2026
Siren, L.L.C.400,000$4.3M0.11%Unchanged
Samsara Biocapital, LLC400,000$4.3M0.47%Unchanged
Aberdeen Group plc400,000$4.3M<0.1%Unchanged
EcoR1 Capital, LLC400,000$4.3M0.21%Unchanged
Nantahala Capital Management, LLC400,000$4.3M0.26%Reduced −50%
Stonepine Capital Management, LLC381,977$4.1M4.09%Reduced −4%
Morgan Stanley202,630$2.2M<0.1%Added +13,024%
Vanguard Capital Management LLC78,680$838K<0.1%Unchanged
Geode Capital Management, LLC19,946$212K<0.1%New
Vanguard Fiduciary Trust Co13,669$146K<0.1%Added +29%
UBS Group AG2,026$22K<0.1%Added +218%
Vanguard Global Advisers, LLC718$8K<0.1%Unchanged
Tower Research Capital LLC (TRC)507$5K<0.1%New
Wells Fargo & Company/mn126$1K<0.1%Unchanged
Pioneer Family Office, LLC96$1K<0.1%Unchanged
Altshuler Shaham Ltd25$266<0.1%Unchanged
Towne Trust Company, N.A5$53<0.1%Unchanged
Activest Wealth Management4$43<0.1%Unchanged
SBI Securities Co., Ltd.2$21<0.1%Unchanged
National Bank Of Canada /fi/1$11<0.1%New